Axogen, Inc.
NASDAQTruist Securities kicked off coverage of AXGN with a Buy rating and a $60 price target today. That adds fresh institutional weight to a stock already up 26% over the past month. Truist's initiation is the latest in a string of positive moves. After Axogen's Q2 print — which beat revenue estimates by 12% and prompted raised 2026 guidance of at least…
AXGN cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for AXGN below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for AXGN are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 26 Aug 2026
Truist Securities kicked off coverage of AXGN with a Buy rating and a $60 price target today. That adds fresh institutional weight to a stock already up 26% over the past month. Truist's initiation is the latest in a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AXGN — free to start on ORTEX.
Sign up for free →Open AXGN on ORTEX